CRISPR Therapeutics
CRSP
39.10
+0.17
+0.44%
CRISPR Therapeutics
US · CRSP
#2057 by market cap
Listed 2016
39.10
+0.17
+0.44%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:54
Quant vs Street three independent views, side by side
StockVane factor grade
D
Momentum strategy signal
Sell
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 1 upgrade vs 0 downgrades among tracked analyst rating changes.
- Most recent: Morgan Stanley moved from Sell to Hold on 2026-08-04.
Analyst consensus 12 analysts
Buy
Avg price target 74.27 +89.9%
Price target rangecurrent 39.10
Low50.00
Avg74.27
High110.00
Buy 67%
Hold 33%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-10 | Needham | -- | Buy | 82.00 |
| 2026-11-10 | H.C. Wainwright | -- | Buy | 80.00 |
| 2026-11-09 | UBS | -- | Hold | 52.00 |
| 2026-11-09 | Piper Sandler | -- | Buy | 110.00 |
| 2026-11-09 | Needham | -- | Buy | 82.00 |
| 2026-11-09 | H.C. Wainwright | -- | Buy | 80.00 |
| 2026-11-09 | J.P. Morgan | -- | Buy | 67.00 |
| 2026-11-08 | Citi | -- | Buy | 90.00 |
| 2026-11-04 | Wells Fargo | -- | Hold | 70.00 |
| 2026-11-04 | BofA Securities | -- | Buy | 80.00 |
| 2026-11-04 | Citi | -- | Buy | 90.00 |
| 2026-11-04 | H.C. Wainwright | -- | Buy | 80.00 |
| 2026-11-03 | Wells Fargo | -- | Hold | 70.00 |
| 2026-11-03 | UBS | -- | Hold | 52.00 |
| 2026-11-03 | Piper Sandler | -- | Buy | 110.00 |
| 2026-11-03 | H.C. Wainwright | -- | Buy | 80.00 |
| 2026-11-03 | RBC Capital | -- | Hold | 50.00 |
| 2026-11-03 | J.P. Morgan | -- | Buy | -- |
| 2026-10-15 | UBS | -- | Hold | 52.00 |
| 2026-10-14 | UBS | -- | Hold | 52.00 |
| 2026-10-09 | BofA Securities | -- | Buy | 81.00 |
| 2026-10-09 | H.C. Wainwright | -- | Buy | 80.00 |
| 2026-10-05 | Needham | -- | Buy | 82.00 |
| 2026-10-02 | Wells Fargo | -- | Hold | 75.00 |
| 2026-09-04 | Citi | -- | Buy | 88.00 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-08-04 | Morgan Stanley | Sell → Hold | 60.00 |
Quote time 2026-11-20 19:54:43 · For reference only, not investment advice and not tailored to your situation.
CRISPR Therapeutics discussion 0 comments